Knockdown of N6AMT1 resulted in a substantial reduction of cell viability in GIST‐882‐IR and GIST‐T1‐IR cells exposed to imatinib (Figure S6B). This evidence concerns the gene HEMK2 and gastrointestinal stromal tumor.